Highlights Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Real-time Estimate Cboe BZX Other stock markets 13:07:57 2024-05-08 EDT			5-day change	1st Jan Change
43.62 ^USD	-0.94%		-1.22%	-14.89%

05-07	Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	MT
05-06	Top Midday Stories: Tyson Shares Tumble on Earnings Miss; Robinhood Receives Wells Notice From SEC Staff; Spirit Airlines to Furlough up to 260 Pilots; Shell in Talks to Sell Malaysian Gas Station Business to Saudi Aramco	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	05-07	MT
Top Midday Stories: Tyson Shares Tumble on Earnings Miss; Robinhood Receives Wells Notice From SEC Staff; Spirit Airlines to Furlough up to 260 Pilots; Shell in Talks to Sell Malaysian Gas Station Business to Saudi Aramco	05-06	MT
Bristol-Myers Squibb Says Applications for Opdivo Accepted by US, European Regulators	05-06	MT
U.S. Food and Drug Administration Accepts Bristol Myers Squibb?s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)	05-06	CI
European Medicines Agency Validates Bristol Myers Squibb?s Application for Opdivo Plus Yervoy for the First-Line Treatment of Adult Patients with Microsatellite Instability?High or Mismatch Repair Deficient Metastatic Colorectal Cancer	05-06	CI
Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration	05-01	MT
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration	05-01	CI
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	04-30
A flurry of corporate results ahead of the Fed's rate decision	04-30
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb	04-30	CI
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	04-30	RE
J&J, Bristol Myers lose challenges to US drug price negotiation program	04-29	RE
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases	04-29	CI
S&P 500 Q1 earnings estimated growth improves; stocks up for week	04-26	RE
Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy	04-26	MT
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma	04-26	CI
Health Care Drops Amid Mixed Earnings -- Health Care Roundup	04-25	DJ
Sector Update: Health Care Stocks Decline Late Afternoon	04-25	MT
Sector Update: Health Care Stocks Drop in Afternoon Trading	04-25	MT
Sector Update: Health Care	04-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm